ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Radiopharm Theranostics Limited

Radiopharm Theranostics Limited (RADOB)

0,002
0,00
(0,00%)
Fermé 05 Juin 8:00AM

Radiopharm Theranostics Limited (RADOB) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,002
( - )
Prix Achat
0,002
Prix Vente
0,002
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
0,002 Plage de 52 semaines 0,01
Cap du marché
Clôture Veille
0,002
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
AUD 2 704 247
Actions en circulation
3 544 216 160
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-1,1
Bénéfice par action (BPA)
-0,02
Chiffre d'affairess (LTM)
16,28M
Bénéfice net (LTM)
-46,58M

À propos de Radiopharm Theranostics Limited

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain me... Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia. Show more

Secteur
-
Industrie
-
Siège social
Carlton, Australia
Fondé
2026
Radiopharm Theranostics Limited est coté dans le secteur de la Australian Stock Exchange avec le ticker RADOB. Le dernier cours de clôture d'Radiopharm Theranostics était de AUD0,00. Au cours de la dernière année, les actions de Radiopharm Theranostics ont été négociées dans une fourchette de prix de AUD 0,002 à AUD 0,01.

Radiopharm Theranostics compte actuellement 3 544 216 160 actions en circulation. La capitalisation boursière d'Radiopharm Theranostics est de AUD7,09 million. Radiopharm Theranostics a un ratio cours/bénéfice (ratio PE) de -1.10.

RADOB Dernières nouvelles

Aucune actualité à afficher pour le moment.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.001-33.33333333330.0030.0030.00231443190.00261723DE
4-0.001-33.33333333330.0030.0030.00231443190.00261723DE
12-0.002-500.0040.0040.00215494550.00298657DE
26-0.006-750.0080.010.00217353250.00526954DE
52-0.006-750.0080.010.00217353250.00526954DE
156-0.006-750.0080.010.00217353250.00526954DE
260-0.006-750.0080.010.00217353250.00526954DE

RADOB - Frequently Asked Questions (FAQ)

What is the current Radiopharm Theranostics Limited share price?
The current share price of Radiopharm Theranostics Limited is AUD 0,002
How many Radiopharm Theranostics Limited shares are in issue?
Radiopharm Theranostics Limited has 3 544 216 160 shares in issue
What is the market cap of Radiopharm Theranostics Limited?
The market capitalisation of Radiopharm Theranostics Limited is AUD 7,09M
What is the 1 year trading range for Radiopharm Theranostics Limited share price?
Radiopharm Theranostics Limited has traded in the range of AUD 0,002 to AUD 0,01 during the past year
What is the PE ratio of Radiopharm Theranostics Limited?
The price to earnings ratio of Radiopharm Theranostics Limited is -1,1
What is the cash to sales ratio of Radiopharm Theranostics Limited?
The cash to sales ratio of Radiopharm Theranostics Limited is 4,57
What is the registered address of Radiopharm Theranostics Limited?
The registered address for Radiopharm Theranostics Limited is 62 Lygon Street, Carlton, Victoria, 3053
What is the Radiopharm Theranostics Limited website address?
The website address for Radiopharm Theranostics Limited is www.radiopharmtheranostics.com

RADOB Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock